跳至主要内容
临床试验/NCT02153411
NCT02153411已完成不适用

Evaluation of aSthma Management in Middle EAst Adult Population

AstraZeneca1 个研究点 分布在 1 个国家目标入组 7,294 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
7,294
试验地点
1
主要终点
Asthma control

研究概览

简要总结

Descriptive study on the management of asthma in asthmatic Middle East adult population : Algeria,Egypt, Irak,Iran, Jordan, Koweit, Lebanon, Qatar,Saudi,Tunisia, UAE

详细描述

Multicentric, transversal, descriptive, epidemiological study, conducted in a random sample of general practitioner and medical specialist (Pulmonologist and/or allergologist) in the public and the private sector.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 130 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.

排除标准

  • Patient concurrently participating to another study. Patient with concomitant pulmonary disease. Patient with psychiatric disorders. Patient consulting for an asthma attack

结局指标

主要结局

Asthma control

时间窗: Up to 1 year

Daytime symptoms Limitation of activities Nocturnal symptoms / awakening Need for reliever /rescue treatment Lung function (PEF or FEV)

次要结局

  • asthma control level(Up to 4 weeks)
  • general and sociodemographic patient's characteristics(up to 1 year)
  • Identify predictive factors of asthma control,(UP to 1 year)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验